Hong Meng, Wu Guodi, Ren Yanli, Wu Shanshan, Zhu Haihong, Chen Zhi
State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, National Medical Center for Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310000, China.
Pathogens. 2025 Jun 2;14(6):554. doi: 10.3390/pathogens14060554.
In recent years, global public health security has encountered significant challenges, with infectious diseases accounting for approximately 25% of global mortality annually. The worldwide pandemic instigated by the novel coronavirus, alongside the persistent threats posed by Ebola, influenza, and multidrug-resistant bacteria, has severely compromised human health, economic development, and social stability. Within this context, the development of rapid and precise pathogen detection technologies has emerged as a critical frontline defense for epidemic prevention and control, serving as a pivotal component in the implementation of the "early detection, early isolation, and early treatment" strategy. The Argonaute (Ago) protein, recognized as a programmable and target-specific activated nuclease, has demonstrated substantial potential in the realm of nucleic acid detection due to its distinctive biological properties, garnering considerable attention. In this study, we delineate the structural characteristics of Ago proteins and elucidate the mechanism underlying their nuclease activity. Furthermore, we review the principles of nucleic acid detection based on Argonaute and provide a comprehensive analysis of recent advancements in related detection systems. Additionally, we compare the advantages of detection based on Argonaute with other detection methodologies. Through a comprehensive analysis, we aim to provide a robust theoretical foundation and an advanced technical reference for the development of new-generation nucleic acid detection platforms with high sensitivity and high specificity.
近年来,全球公共卫生安全面临重大挑战,传染病每年约占全球死亡率的25%。新型冠状病毒引发的全球大流行,以及埃博拉病毒、流感和多重耐药细菌带来的持续威胁,严重损害了人类健康、经济发展和社会稳定。在此背景下,快速、精准的病原体检测技术的发展已成为疫情防控的关键前沿防线,是实施“早发现、早隔离、早治疗”策略的关键组成部分。Argonaute(Ago)蛋白被认为是一种可编程的、靶向特异性激活核酸酶,因其独特的生物学特性,在核酸检测领域展现出巨大潜力,备受关注。在本研究中,我们描述了Ago蛋白的结构特征,并阐明了其核酸酶活性的机制。此外,我们回顾了基于Argonaute的核酸检测原理,并对相关检测系统的最新进展进行了全面分析。此外,我们还比较了基于Argonaute检测与其他检测方法的优势。通过全面分析,我们旨在为开发具有高灵敏度和高特异性的新一代核酸检测平台提供坚实的理论基础和先进的技术参考。